Frozen Embryo Transfer: Increased Risk of Hypertension in Pregnancy Confirmed

Recent research, corroborated by various international studies and highlighted by a recent publication in the European Medical Journal, indicates a significant link between frozen embryo transfer (FET) and an increased risk of hypertensive disorders during pregnancy. This finding holds crucial implications for individuals considering or undergoing assisted reproductive technologies (ART), particularly in regions like India where IVF treatments are increasingly prevalent. Multiple studies have consistently demonstrated that women who conceive through FET face a higher likelihood of developing hypertensive disorders in pregnancy (HDP), including gestational hypertension and preeclampsia, when compared to those who conceive naturally or through fresh embryo transfer (FET) cycles. For instance, one large study, published in the American Heart Association journal *Hypertension*, found that pregnancies resulting from frozen embryo transfer were associated with a 74% higher risk of high blood pressure-related pregnancy complications compared to those conceived via fresh embryo transfer or natural conception. Another study indicated that the risk of hypertensive disorders in pregnancy was almost twice as high in FET pregnancies compared to natural conception (7.4% vs. 4.3%). Initially, it was debated whether this elevated risk was due to parental factors associated with infertility or the IVF treatment process itself. However, large-scale studies utilizing sibling comparisons have provided strong evidence that the increased risk is primarily linked to the frozen embryo transfer process rather than inherent parental risk factors. This means that when the same mother conceived siblings using different methods (e.g., one naturally, one via FET), the FET pregnancy still carried a higher risk of HDP. The underlying mechanisms for this increased risk are still being investigated, but a prominent hypothesis points to the absence of the corpus luteum in certain types of FET cycles, particularly programmed cycles that suppress ovulation. The corpus luteum plays a vital role in secreting vasoactive hormones, such as relaxin, which are essential for the maternal cardiovascular system to adapt to the physiological demands of pregnancy. When these hormones are absent or insufficient, it may compromise arterial compliance during early gestation, thereby increasing the risk of HDP. Studies have shown that preeclampsia rates were significantly higher in women receiving frozen embryos under a programmed cycle without a corpus luteum compared to those with a modified natural cycle with a corpus luteum. While frozen embryo transfer offers several advantages, including reduced risk of ovarian hyperstimulation syndrome (OHSS) and greater flexibility in timing, these findings underscore the need for a comprehensive understanding of both the benefits and potential risks. The practice of freezing all embryos ('freeze-all' approach) has become more common due to advancements in cryopreservation technologies and improved success rates. However, experts emphasize that careful consideration of all potential benefits and harms is necessary before routinely adopting a 'freeze-all' strategy. The European Medical Journal has published a recent article on February 9, 2026, further solidifying these findings, stating that frozen embryo transfer was associated with a higher risk of pregnancy-induced hypertension compared with fresh embryo transfer, despite showing similar perinatal complication rates in ongoing IVF/ICSI pregnancies. This latest publication reinforces prior reviews in the same journal and others, which had already evidenced a possible relation between FET and hypertension. The relevance of this news for an Indian audience is particularly high. Assisted reproductive technologies, including IVF and FET, are increasingly sought after by couples in India. Fertility centers across India report comparable success rates for FET to international standards, highlighting the widespread adoption of these techniques. With an increasing number of individuals opting for ART, understanding and mitigating potential maternal health risks like hypertension becomes paramount for patient safety and improved pregnancy outcomes. Healthcare providers in India, like those at Sabine Hospital which performs a high number of embryo transfers, would need to integrate these findings into their counseling and monitoring protocols. Close monitoring of blood pressure throughout pregnancy is crucial for women who conceive via FET, enabling early detection and management of hypertensive disorders. Most IVF pregnancies are healthy and uncomplicated, but awareness of specific risks allows for better patient care. In conclusion, the claim that frozen embryo transfer is linked to an increased risk of hypertension in pregnancy is well-verified and supported by robust scientific evidence from multiple credible sources. The headline is accurate and reflects the consensus of recent research. This is a critical piece of medical information for both clinicians and patients globally, particularly in countries like India where ART use is expanding.

Frequently Asked Questions

Read Full Story on Quick Digest